Project Details
| Short title | PMC TTAC-0001-06 |
|---|---|
| Acronym | Keynote-C14 |
| Status | Active |
| Effective start/end date | 4/08/22 → 27/04/27 |
CTU: A Phase II, Open-Label, Multicenter Study of Olinvacimab in Combination with Pembrolizumab in Patients with Metastatic Triple-Negative Breast Cancer
- Sabanathan, Dhanusha (Primary Chief Investigator)
- Chester, Catherine (Clinical Trial Unit Staff)
- Chapman, Nicola (Clinical Trial Unit Staff)
Project: Research